1. Home
  2. SPRC vs PFSA Comparison

SPRC vs PFSA Comparison

Compare SPRC & PFSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SciSparc Ltd.

SPRC

SciSparc Ltd.

HOLD

Current Price

$7.14

Market Cap

2.5M

Sector

Health Care

ML Signal

HOLD

PFSA

Profusa Inc.

SELL

Current Price

$0.56

Market Cap

2.5M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
SPRC
PFSA
Founded
2004
2009
Country
Israel
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5M
2.5M
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
SPRC
PFSA
Price
$7.14
$0.56
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
309.4K
6.7M
Earning Date
04-24-2026
04-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.27
$0.05
52 Week High
$9.03
$4.22

Technical Indicators

Market Signals
Indicator
SPRC
PFSA
Relative Strength Index (RSI) 61.52 43.67
Support Level $3.46 $0.43
Resistance Level $8.90 $0.66
Average True Range (ATR) 1.18 0.07
MACD 0.22 -0.01
Stochastic Oscillator 68.58 38.37

Price Performance

Historical Comparison
SPRC
PFSA

About SPRC SciSparc Ltd.

SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.

About PFSA Profusa Inc.

Profusa Inc is a clinical-stage digital health and medical technology company. The Company's technology enables the development of bioengineered sensors that are designed to become one with the body to detect and continuously transmit actionable, clinical-grade data for personal and medical use. The Company's first offering in the European Union, the Lumee Oxygen Platform, is designed to report reliable tissue oxygen levels at various regions of interest, both acutely and long-term. The Lumee Oxygen Platform has been designed for use in applications where monitoring of compromised tissue is beneficial, such as peripheral artery disease that results in narrowing of blood vessels and reduced blood flow to the lower limbs; chronic wounds that do not heal properly; and reconstructive surgery.

Share on Social Networks: